Member Info for Wigster77

Yes, lets hope the Synairgen team have some good sales people who can adequately highlight the huge potential of SNG001. Last thing we would want is to be sold short, but purchases like the one SYN00GOLD has helpfully informed us about below, show what's possible with belief in a product and some vision.

I certainly hope a £1 T/O doesn't happen, gollumk. With patience, the value of SNG will be a lot higher.

The potential for SNG001 is huge. I couldn't see Synairgen letting it go for peanuts. Stay patient, keep the faith...

...and have a great weekend! GLA.

I did put it in inverted commas FTC7!!

I'm trying my best to be patient and take a longer-term view. Not easy, as we all desperately want to recoup some/all of our February losses sooner rather than later.
I trust the science - and the positive evidence for Interferon Beta continues to mount up, so that gives a lot of hope. As for Synairgen themselves? I have slightly less trust in them to be able to extract the maximum value/potential from the drug they have, but I'd still rather stick with it now rather than take a punt with something else. Hopefully the "upbeat" look of Richard Marsden in recent interviews was not just for show and there really are useful conversations going on "at haste", which will bear fruit at some point. I guess time will tell...

DYOR/GLA!!!

"It was down 15% when I went out a hour ago now down 27% did I liss anything"

The new cheaper tea-bags that Maude negotiated a fantastic price on are actually out of date and taste like crap.

I guess we're not expecting too much from the Webcast and Q&A session at 12pm? Are these things usually just a regurgitation of the announcement and answers to carefully selected "non awkward" questions?

$1.9Bn (or shall we say £9.50/share) sounds fine Brighty1...where do I sign?

I did hear a rumour...and I stress "rumour", that she was indeed back after trawling the world and finding PG Tips a massive 75% cheaper than Synairgen previously paid. I'm surprised this info didn't warrant an RNS :-)

Sparkyboy - I believe TLWilliams stopped posting due to the petty infighting and trolls which plagued the board a few weeks back. A shame as his posts were very salient and balanced.
Aether, yes would be good to get a relentless torrent of good news now.

Just reading this article about Pfizer acquiring Biohaven Pharma for $11.6Bn.

https://www.ft.com/content/ea9bb9bc-b5ec-4278-ab42-1f5f14a1a76f

A week or so old news now, but the following stood out:

Evan Seigerman, analyst at BMO Capital Markets, said the acquisition was a good fit for Pfizer and provided potential cost synergies.

“Nurtec checked five of six key criteria for Pfizer in picking an asset to acquire, including: high complement to the portfolio, high level of clinical de-risking, high commercial potential, low infrastructure requirements, and low FTC [antitrust] risk,” he said.

However, Seigerman said Pfizer investors were likely to push for more deals and that the company still had had almost $200bn in firepower.
----
I wonder how many of the 6 criteria SNG001 ticks (or could potentially tick)?

Also, good to know that Pfizer aren't running short of cash and have plenty of "firepower" for more deals :-)

DYOR & GLA

I fell into the same trap today as well, altube...I think it was seeing RM looking so positive yesterday!!

Yes, just a waiting game now. Hang in there!!

- Company update next Wednesday
- Activ2-P2 data "any minute"
- NIH news last night looking promising that SNG001 with have a route forward with them
- Lot of promising conversations being had according to an upbeat RM in his interview

DYOR & GLA

Great find Tommy!!
Sounds promising...I wonder if this news was part of some of the "great conversations and discussions" RM referred to in his interview today?
Certainly Activ2 P2 data can't be far off, and will hopefully give Synairgen a fast track route into contributing to the work these new AVIDD centres will do.

GLA

Manifesto - no problem, you may just need to remind me whether it was Tesco Value or Lidl that you prefer :-)

Agree with previous posts that it is nice to see RM looking quite positive and, dare I say, with some semblance of a plan hatching.
I've had my frustrated moan like a few others and am still not keen on "yet more trials", but the aforementioned positivity has encouraged me to put my Patient Hat on and buckle up for the ride.

...you never know, we might even be lucky and get some unexpected GOOD news along the way. It'd be no less than us investors deserve.

GLA!!

I think you're right Doc. Last years was notified on a specific RNS, for June 18th and was a "closed meeting"

B2HS2L - I couldn't comment on side effects for SNG001 or indeed any other drug out there without doing further research, but you can read the safety summary for SNG001 vs Placebo (with current SOC) here:

https://synairgen.ams3.digitaloceanspaces.com/ATS-2022-SPRINTER-Poster-Final-17052022.pdf

This reads favourable vs current SOC to me, unless I'm mis-reading it.

Looks to me like SNG001 should be the new "standard of care". Good safety profile, ph-neutral formula using natural proteins, potent activity against all variants of Covid. SAVES LIVES.

From RNS of 5th April:

The Company also announces today that it will issue its FY 2021 financial results on 25 May 2022 and provide a general company update then.